Design and Properties of NCCG-gp41, a Chimeric gp41 Molecule with Nanomolar HIV Fusion Inhibitory Activity
Open Access
- 1 August 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (31), 29485-29489
- https://doi.org/10.1074/jbc.c100317200
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Is an HIV vaccine possible?Nature Medicine, 1999
- Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41The EMBO Journal, 1998
- Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibodyNature, 1998
- HIV Entry and Its InhibitionCell, 1998
- Co-receptors for HIV-1 entryCurrent Opinion in Immunology, 1997
- Atomic structure of the ectodomain from HIV-1 gp41Nature, 1997
- A trimeric structural domain of the HIV-1 transmembrane glycoproteinNature Structural & Molecular Biology, 1995
- The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus InfectionJournal of Biological Chemistry, 1995
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994
- A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.Proceedings of the National Academy of Sciences, 1992